Table 3.
Combination of current ELN risk classification with TriAS leads to a refined ELN + TriAS classification showing three groups with adverse (≤25 %), intermediate (50–60 %), and favorable (>60 %) survival after 3 years
| ELN risk | TriAS | Number of patients | 3-year OS (%) | Median OS (days) | Refined ELN + TriAS |
|---|---|---|---|---|---|
| Favorable | 1 | 24 | 77.4 | Not reached | Favorable |
| Favorable | 2 | 59 | 75.4 | 3555 | Favorable |
| Intermediate 1/2 | 1 | 7 | 68.6 | Not reached | Favorable |
| Favorable | 3 | 46 | 58.1 | 1805 | Intermediate |
| Favorable | 4 | 12 | 52.1 | Not reached | Intermediate |
| Intermediate 1/2 | 2 | 54 | 50.9 | 1193 | Intermediate |
| Adverse | 1 | 2 | 50.0 | Not reached | Intermediate |
| Intermediate 1/2 | 3 | 78 | 25.6 | 366 | Adverse |
| Intermediate 1/2 | 4 | 22 | 23.9 | 214 | Adverse |
| Adverse | 2 | 24 | 21.4 | 368 | Adverse |
| Adverse | 3 | 30 | 18.2 | 347 | Adverse |
| Adverse | 4 | 17 | 0.0 | 214 | Adverse |